⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for antiemetics

Every month we try and update this database with for antiemetics cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid CancerNCT01046461
Solid Tumour
Postoperative N...
Ramosetron, Apr...
18 Years - 75 YearsHallym University Medical Center
Fosaprepitant in Patients Receiving Ifosfamide-based RegimenNCT01490060
Sarcoma
Chemotherapy-in...
Effects of Chem...
Adverse Effects...
Fosaprepitant
Dexamethasone
5HT3 receptor a...
Ifosfamide-base...
Doxorubicin
Mesna
Ifosfamide
Vincristine
18 Years - 65 YearsM.D. Anderson Cancer Center
A Trial of Perifosine in Patients With Chemo-Insensitive SarcomasNCT00401388
Chondrosarcomas
Alveolar Soft P...
Extra Skeletal ...
Perifosine
Loperamide
Allopurinol
Antiemetics
13 Years - AEterna Zentaris
Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer SurgeryNCT05408676
Mammary Cancer
PONV
electric stimul...
18 Years - 64 YearsFudan University
Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast CancerNCT05242874
Chemotherapy-in...
Fosaprepitant ,...
Fosaprepitant ,...
18 Years - 70 YearsHenan Cancer Hospital
Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.NCT03606369
Breast Neoplasm
Antineoplastic ...
Antiemetics
Quality of Life
Palonosetron
Ondansetron
18 Years - Instituto Nacional de Cancerologia de Mexico
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)NCT01636947
Nausea
Vomiting
Aprepitant
Aprepitant Plac...
Ondansetron
Dexamethasone
Ondansetron Pla...
Rescue Therapy ...
21 Years - Merck Sharp & Dohme LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: